Dialysis: NxStage notches 3rd Euro win with CE Mark for OneSite needle

February 27, 2013 by Arezu Sarvestani

NxStage Medical touts its 3rd European regulatory win this month with CE Mark approval for its OneSite single needle dialysis technology.

NxStage Medical logo

Massachusetts medical device maker NxStage Medical (NSDQ:NXTM) is on a roll, notching its 3rd regulatory win this month with CE Mark approval in the European Union for its OneSite single needle for dialysis patients.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp